Tersus Life Sciences is a supplement company located in Bonita Springs, Florida that developed the science behind Provinal®–an ultrapurified form of Omega 7 (Palmitoleic acid)–the next generation of Omega fatty acids that have been shown to possess broad properties to combat diabetes, metabolic syndrome, and atherosclerosis.
Provinal® Purified Omega 7 fatty acids are purified to express high levels of palmitoleic acid (C16:1n7).
In early 2010, Tersus Life Sciences was a recipient of an Affordable Care Act Grants to Support Groundbreaking Biomedical Research, and has been working on the parallel development of Provinal™ as a nutritional supplement, as well as a food additive.
Dr. Michael Roizen, Chairman of the Wellness Institute at the Cleveland Clinic, who has joined Tersus Life Sciences as the Chairman of the Scientific Advisory Board said: “This could have a huge benefit for our populations as a whole because Metabolic syndrome, Insulin resistance, and Diabetes are big things we need to tackle for us to be more competitive for jobs, and the United States to be more competitive as a society. We need more studies, but this could really be a great addition—that’s why I joined Tersus Life Sciences—to see if we could get more data on the benefits and risks of purified omega-7.”
The raw materials required to produce Provinal® are abundant and sustainable, and the company has secured a global supply.